Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 16, 2018
April 17, 2020
a2b09b4f-527f-406f-a71d-c6e62d4737ad
Related Documents
Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs
Guidance DocumentOctober 3, 2018Center for Drug Evaluation and Research
Pediatric HIV Infection: Drug Development for Treatment
Guidance DocumentMarch 20, 2019Center for Drug Evaluation and Research
Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 24, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.